Niagen Bioscience Inc

NAGE | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.07

+$0.03 (+0.99%)

Sep 22, 2026, 12:06 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Cash & Equivalents	64.79M	44.51M	27.17M	20.29M	28.02M	16.5M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	425K	368K	383K	497K	723K	625K
Receivables	9.74M	7.77M	5.23M	8.48M	5.23M	2.69M
Inventory	20.42M	9.19M	14.53M	14.68M	13.6M	11.68M
Other Current Assets	1.85M	2.63M	2.6M	3.12M	200K	200K
Total Current Assets	96.81M	64.1M	49.53M	46.57M	48.91M	32.22M
Property-Plant & Equipment	3.52M	3.45M	4.54M	6.32M	7.36M	4.43M
Goodwill & Intangibles	5.66M	359K	510K	671K	857K	1.08M
Total Long-Term Assets	9.6M	4.18M	5.43M	7.49M	8.94M	6.14M
Total Assets	106.41M	68.28M	54.96M	54.06M	57.84M	38.36M
Account Payables	10.8M	8.53M	10.23M	9.68M	10.42M	9.45M
Deferred Revenue	n/a	611K	195K	157K	161K	278K
Short-Term Debt	1M	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	8.12M	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	19.92M	17.95M	20.62M	17.87M	17.61M	16.48M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	5.47M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	9.95M	4.24M	5.89M	7.52M	8.5M	5.46M
Total Liabilities	29.87M	22.18M	26.51M	25.39M	26.11M	21.93M
Total Debt	2.82M	2.65M	3.28M	4.26M	4.7M	1.64M
Book Value	76.53M	46.09M	28.46M	28.67M	31.73M	16.42M
Book Value Per Share	0.90	0.58	0.38	0.41	0.47	0.27
Common Stock	79K	77K	75K	74K	68K	62K
Retained Earnings	-164.53M	-181.91M	-190.46M	-185.49M	-168.95M	-141.83M
Comprehensive Income	-9K	-4K	-4K	-3K	-2K	-3K
Shareholders Equity	76.53M	46.09M	28.46M	28.67M	31.73M	16.42M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a